A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group
For this reason, patients under semaglutide could benefit from this nutritional therapy, specifically those with more complicated metabolic profiles and who seek for substantial weight loss in the initial phase
Care Cancer 26, 29292935
* Available in English, Spanish, Japanese, Portuguese, French, Italian, German, Polish Information for individuals residing in the European Union: Tests performed on persons established in the EU are intended for lifestyle and wellness purposes and are not intended to provide information intended for use in the provision of diagnostic or therapeutic services
[DOI] [PMC free article] [PubMed] [Google Scholar] 91.Campos CA, Bowen AJ, Han S, Wisse BE, Palmiter RD, Schwartz MW